An evaluation of Haemophilus influenzae type b (Hib) vaccination and description of Risk factors for Hib vaccine failure in Europe 1996-1998

Surveillance report

During the past decade, conjugate vaccines against Haemophilus influenzae type b (Hib) infection have been introduced for routine use in infants into several countries in Europe. Currently, the vaccination programmes in these countries differ with respect to the choice of vaccine, the schedule for primary immunisation, and the use of a booster dose in the second year of life.